- Home
- SYTA vs CERO Comparison
SYTA vs CERO Comparison
Compare SYTA & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- CERO
- Stock Information
- Founded
- SYTA 1986
- CERO 2017
- Country
- SYTA Canada
- CERO United States
- Employees
- SYTA N/A
- CERO N/A
- Industry
- SYTA Telecommunications Equipment
- CERO
- Sector
- SYTA Telecommunications
- CERO
- Exchange
- SYTA Nasdaq
- CERO Nasdaq
- Market Cap
- SYTA 3.1M
- CERO 3.1M
- IPO Year
- SYTA 2020
- CERO N/A
- Fundamental
- Price
- SYTA $2.11
- CERO $0.72
- Analyst Decision
- SYTA
- CERO
- Analyst Count
- SYTA 0
- CERO 0
- Target Price
- SYTA N/A
- CERO N/A
- AVG Volume (30 Days)
- SYTA 701.7K
- CERO 1.0M
- Earning Date
- SYTA 05-15-2025
- CERO 05-16-2025
- Dividend Yield
- SYTA N/A
- CERO N/A
- EPS Growth
- SYTA N/A
- CERO N/A
- EPS
- SYTA N/A
- CERO N/A
- Revenue
- SYTA $11,988,979.00
- CERO N/A
- Revenue This Year
- SYTA $75.92
- CERO N/A
- Revenue Next Year
- SYTA $19.72
- CERO N/A
- P/E Ratio
- SYTA N/A
- CERO N/A
- Revenue Growth
- SYTA 41.59
- CERO N/A
- 52 Week Low
- SYTA $1.82
- CERO $0.65
- 52 Week High
- SYTA $885.60
- CERO $255.00
- Technical
- Relative Strength Index (RSI)
- SYTA 37.74
- CERO 24.94
- Support Level
- SYTA $1.88
- CERO $0.66
- Resistance Level
- SYTA $2.24
- CERO $0.80
- Average True Range (ATR)
- SYTA 0.33
- CERO 0.12
- MACD
- SYTA 0.10
- CERO 0.03
- Stochastic Oscillator
- SYTA 12.43
- CERO 7.97
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.